COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Manz AG decides to sell its battery cell production equipment business and specifies its forecast for the 2024 fiscal year
Manz AG decides to sell its battery cell production equipment business and specifies forecast for 2024 fiscal year amid challenging market conditions. Company will focus on industrial automation -
COMMUNIQUÉ DE PRESSE
Condor Provides Update on Canada Postal Strike and Voting at the Company's 2024 Annual General and Special Meeting
Condor Resources Inc. advises shareholders to vote online or by phone for the upcoming annual general and special meeting on December 11, 2024. Meeting materials available online -
-
COMMUNIQUÉ DE PRESSE
Electrovaya Provides a Shareholder Update including Unaudited Preliminary FY2024 Annual Financial Results and Positive Outlook for 2025
Electrovaya Inc. reports unaudited FY2024 revenue estimate of $45 million with 31% gross margin, anticipates improved FY2024 operating profit and FY2025 revenues exceeding $60 million driven by renewed demand from largest end users. US EXIM Bank approves $51 million direct loan for Jamestown battery manufacturing expansion -
COMMUNIQUÉ DE PRESSE
RE Royalties Enters into Loan and Royalty Agreement with SolarBank Corporation for CAD $3.0 Million
RE Royalties Ltd. provides a $3.0 Million secured loan to Solar High Yield Projects #1 Ltd., a subsidiary of SolarBank Corp., for Battery Energy Storage System projects in Ontario, Canada -
COMMUNIQUÉ DE PRESSE
Interactive Strength Inc. (Nasdaq:TRNR) Successfully Concludes Hearings Panel Appeal and Confirms Demonstrated Compliance Letter for Continued Nasdaq Listing
Interactive Strength Inc. (NASDAQ:TRNR) successfully concludes Nasdaq Stock Market compliance process, surpassing minimum Stockholder's Equity level for Q3 and focusing on growth strategy -
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Marinomed Biotech AG: Publication of a report on the exclusion of subscription rights for a possible second cash capital in-crease of up to 154,053 shares
Marinomed Biotech AG plans a possible second cash capital increase and will publish a report on the exclusion of subscription rights. Negotiations ongoing with investors -
